menu

Medical Industry Feature: Easing the Emergency Department Pressure with High-Sensitivity Troponin T

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Easing the Emergency Department Pressure with High-Sensitivity Troponin T

Easing the Emergency Department Pressure with High-Sensitivity Troponin T
RestartResume

When healthcare needs to improve patient outcomes and minimize costs, how can Gen 5 Troponin T enable change in the Emergency Department?

  • Sponsored by

  • Overview

    Although 6 million patients visit the Emergency Department every year with chest pain symptoms1, less than 4 percent of those visits lead to a diagnosis of acute myocardial infarction2.

    To address this gap, Dr. Jennifer Caudle is joined by Dr. Christopher Baugh, Vice Chair of Clinical Affairs at Brigham and Women's Hospital and Associate Professor at Harvard Medical School in Boston Massachusetts, who discusses the adoption of Elecsys Troponin T Gen 5 across the system's Emergency Departments.

    References

    1. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics, https://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2013_ed_web_tables.pdf (accessed February 27, 2020). 
    2. Hsia, R.Y., Z. Hale and J.A. Tabas. (2016). A National Study of the Prevalence of Life-Threatening Diagnoses in Patients with Chest Pain. JAMA Internal Medicine 176(7):1029–1032. 

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/2/20